User Guide
Why can I only view 3 results?
You can also view all results when you are connected from the network of member institutions only. For non-member institutions, we are opening a 1-month free trial version if institution officials apply.
So many results that aren't mine?
References in many bibliographies are sometimes referred to as "Surname, I", so the citations of academics whose Surname and initials are the same may occasionally interfere. This problem is often the case with citation indexes all over the world.
How can I see only citations to my article?
After searching the name of your article, you can see the references to the article you selected as soon as you click on the details section.
 Views 8
 Downloands 3
Giant Silent Corticotropic Adenoma In An Adolescent: A Case Report
2022
Journal:  
International Journal of Advanced Research
Author:  
Abstract:

Pituitary tumors in children and adolescents are dominated by craniopharyngiomas (80-90%) followed by adenomas. Silent pituitary adenomas in children and adolescents are rare represent only 4-6% of all adenomas. We present the case of a silent giant corticotropic adenoma revealed by pituitary tumoral syndrome in an adolescent. This is a 17-year-old patient operated for an invasive interstellar and suprasellar mass of 34x63x42 mm revealed by intense headaches, blindness in the left eye and a significant decrease in visual acuity in the right eye evolving for 1 month in a context of growth retardation for 4 years, without signs of associated pituitary hormonal hypersecretion. immunohistochemistry had concluded to a corticotropic adenoma. control hypothalamic-pituitary MRI showed persistence of the sellar and suprasellar mass of 33x31x34 mm. The patient had been referred for revision surgery. Silent adenomas are rare in childhood and adolescence let alone giant corticotropic silent adenomas. They are associated with significant morbidity due to their location, their mass effect and / or their interference with normal pituitary hormonal functions. Surgical treatment remains the first-line treatment. Long-term follow-up remains essential to detect recurrence and to manage the various pituitary deficits.

Keywords:

2022
Author:  
0
2022
Author:  
Citation Owners
Information: There is no ciation to this publication.
Similar Articles












International Journal of Advanced Research

Field :   Sosyal, Beşeri ve İdari Bilimler

Journal Type :   Uluslararası

Metrics
Article : 10.413
Cite : 719
© 2015-2024 Sobiad Citation Index